Loading insider details...
Beta
Latest Form 4 (Feb 6, 2026): Grant/Award of 102,885 MANE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 6, 2026 | Veradermics, Inc (MANE) | Grant/Award | 102,885 | n/a |
| Aug 20, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Exercise/Conversion | 18,714 | $690.4K |
| Mar 11, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Sale | 8,636 | $573.2K |
| Mar 8, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Exercise/Conversion | 13,132 | n/a |
| Mar 5, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/Award | 26,227 | n/a |
| Feb 27, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Exercise/Conversion | 7,907 | n/a |
| Feb 5, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/Award | 11,860 | n/a |